We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Palvella Therapeutics Inc | NASDAQ:PVLA | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 14.25 | 13.70 | 15.60 | 246 | 13:19:51 |
EXHIBIT 99.1
JOINT FILING AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Palvella Therapeutics, Inc.
Date: January 8, 2025
FRAZIER LIFE SCIENCES PUBLIC FUND, L.P.
By: FHMLSP, L.P., its General Partner
By: FHMLSP, L.L.C., its General Partner
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FHMLSP, L.P.
By: FHMLSP, L.L.C., its General Partner
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FHMLSP, L.L.C.
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FRAZIER LIFE SCIENCES PUBLIC OVERAGE FUND, L.P.
By: FHMLSP Overage, L.P., its General Partner
By: FHMLSP Overage, L.L.C., its General Partner
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FHMLSP OVERAGE, L.P.
By FHMLSP Overage, L.L.C., its General Partner
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FHMLSP OVERAGE, L.L.C.
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FRAZIER LIFE SCIENCES XI, L.P.
By: FHMLS XI, L.P., its General Partner
By: FHMLS XI, L.L.C., its General Partner
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FHMLS XI, L.P.
By: FHMLS XI, L.L.C., its General Partner
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FHMLS XI, L.L.C.
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FRAZIER LIFE SCIENCES X, L.P.
By: FHMLS X, L.P., its General Partner
By: FHMLS X, L.L.C., its General Partner
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FHMLS X, L.P.
By: FHMLS X, L.L.C., its General Partner
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
FHMLS X, L.L.C.
By: /s/ Steve R. Bailey
Steve R. Bailey, Chief Financial Officer
Date: January 8, 2025
By: *
James N. Topper
Date: January 8, 2025
By: *
Patrick J. Heron
Date: January 8, 2025
By: **
Albert Cha
Date: January 8, 2025
By: **
James Brush
Date: January 8, 2025
By: ***
Daniel Estes
Date: January 8, 2025
By: /s/ Steve R. Bailey
Steve R. Bailey, as Attorney-in-Fact
*This Joint Filing Agreement was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on March 29, 2016.
**This Joint Filing Agreement was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021.
***This Joint Filing Agreement was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022.
1 Year Palvella Therapeutics Chart |
1 Month Palvella Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
